UnipicK+ was used for single-cell transcriptomics study of olfactory sensory neurons to unravel mechanisms ofodor encoding. The results were published in Current Biology by Firmenich investigators.

NDX technology was used in a study of Circulating Tumor Cells in Early-Stage Non-Small Cell Lung Cancer.

NDX technology was used in a single cell transcriptional analysis of tumor cell clusters in epithelial ovarian cancer.

Single cells were isolated using NDX instrument in a study of individual CTCs associated with tumor progression during EGFR-targeted therapy.

NDX exhibits its products at the 64th Annual Meeting of Biophysical Society in San Diego.

A new study “Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues” published in Neuro Oncology Advances uses NeuroInDx technology to collect individual cells.

NDX presented its latest work at The 13th Biennial Conference of Chinese Neuroscience Society, Suzhou, China.

NDX presented its technology at the 10th IBRO Congress of Neuroscience in Daegu, Korea.

NDX exhibited its products at the ISSCR annual meeting, Los Angeles.

NeuroInDx presents its latest technology at Single Cells: Technology to Biology, Singapore.